The association between SYNE4 (Spectrin Repeat Containing Nuclear Envelope Family Member 4) and Genetic Hearing Loss is reported, with clinical genetic testing available.
Sources1
Clinical variants0
Symptoms0
Compounds0
Trials0
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.